Information
-
Trademark
-
79339266
-
Serial Number
79339266
-
Registration Number
7082665
-
International Classifications
-
Filing Date
October 18, 2021
3 years ago
-
Registration Date
June 20, 2023
a year ago
-
Transaction Date
September 25, 2023
a year ago
-
Status Date
June 20, 2023
a year ago
-
Published for Opposition Date
April 04, 2023
a year ago
-
Location Date
June 20, 2023
a year ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
BUTLER, MIDGE FAE
-
Attorney Docket Number
118171.0001
Attorney Name
Andrew Roppel
Law Office Assigned Location Code
L70
-
Owners
Mark Drawing Code
3000
Mark Identification
EXELIOM BIOSCIENCES
Case File Statements
- GS0051: Pharmaceutical products for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; natural medicines for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; isotopes for medical use; yeast for medical, veterinary or pharmaceutical use; microbicides, namely, germicides for the prevention and treatment of immune-mediated diseases and infectious diseases; chemical preparations for medical use, namely, chemical preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; biochemical preparations for medical purposes, namely, biochemical preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; bacteriological preparations for medical use, namely, bacteriological preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; biological preparations for medical use, namely, biological preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; mixed biological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of the immune-mediated diseases and infectious diseases; preparations of trace elements for human and animal consumption, namely, nutritional supplements, vitamins and dietetic beverages for the prevention and treatment of immune-mediated diseases and infectious diseases; preparations for enemas; nucleic acid sequences for medical and veterinary use; vaccines; vaccines for human use; blood substitutes for human use; beverages for babies, namely, infant formula, powdered milk for babies, baby food in beverage form, and nutritionally fortified beverages for medical purposes; mother's milk substitutes; drug delivery release agents in the nature of tablet coatings which facilitate the release of nutritional supplements; dietetic foods for clinical nutrition for medical purposes; dietetic foods adapted for medical purposes for sick people; dietetic foods for medical use; dietetic food adapted for diabetics; antioxidants; dietetic beverages for medical use; food supplements; protein supplement shakes; fruit juice beverages for diabetics, adapted for medical purposes; enzyme food supplements; protein food supplements; food supplements for controlling cholesterol; food supplements for infants; food supplements suitable for human consumption; food supplement with cosmetic effect; dietary supplements for persons with special diets; probiotic supplements; prebiotic supplements; dietetic confectionery products for medical use, namely, medicated candies for the prevention and treatment of intestinal omeothesis; dietary fibers, namely, dietary fiber for the prevention and treatment of intestinal omeothesis; beverage mixtures used as food supplements; slimming pills; freeze-dried food for medical use; medicinal drinks; vitamin and mineral products, namely, vitamin and mineral preparations for the prevention and treatment of immune-mediated diseases and infectious diseases; dietetic foods adapted for medical use; dietetic preparations adapted for medical purposes; nutraceutical preparations for therapeutic or medical use, namely, nutraceuticals for the prevention and treatment of intestinal omeothesis; medicinal preparations used as additives for food intended for human consumption, namely, medicinal preparations for the prevention and treatment of intestinal omeothesis; multivitamin preparations; dietetic preparations for medical use; dietetic infusions for medical use; medicated food supplements; amino acids for pharmaceutical use; rubbing compounds for pharmaceutical use; milk ferments for pharmaceutical use; ferments for medical or veterinary use; ferments for pharmaceutical use; probiotic bacterial substances for medical use; medicinal herbs; medicines for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; plant-based medicines for the treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; medicated lozenges; lozenges for pharmaceutical use; anti-neoplastic preparations of microbial origin, namely, pharmaceutical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; plant preparations for medical use, namely, plant preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; bacteriological preparations for pharmaceutical use; biotechnological preparations for medical use; chemical-pharmaceutical preparations; chemical preparations for pharmaceutical use; pharmaceutical preparations for human use; probiotic preparations for medical use to help maintain a natural balance of the intestinal flora in the digestive system; chemical products for pharmaceutical use, namely, chemical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; injectable pharmaceutical products, namely, injectable pharmaceutical preparations for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; purgatives; medicinal preparations and substances, namely, drug delivery agents for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; mineral preparations and antibacterial substances for medical use; pharmaceutical preparations and substances, namely, pharmaceutical products for the prevention and treatment of immune-mediated diseases, infectious diseases and intestinal omeothesis; preparations of microorganisms for medical and veterinary use; biological reagents for medical use; chemical reagents for medical use; diagnostic reagents for medical use; chemical analysis reagents for medical use; reagents for microbiological analysis for medical use; regents for medical diagnosis; reagents for diagnostic tests for medical use; nutritive substances for microorganism cultures
- GS0351: Compilation of scientific information into computer databases
- GS0441: Health care services for human beings; pharmaceutical advice, namely, providing medical information services; advice in the field of dietetics and nutrition; health counseling services; information regarding health; provision of information relating to dietary and nutritional supplements; provision of information relating to dietary and nutritional recommendation services; providing information regarding food supplements and nutrition; preparing medical reports relating to health care, namely, providing medical information to patients; information and advisory services with respect to health; Advisory services relating to medical heath care; medical advisory services in dietetics; genetic testing on animals for diagnostic or treatment purposes; advisory and information services provided via the Internet with respect to development and research of pharmaceutical products; advisory and information services with respect to development and research of pharmaceutical products; advisory and information services with respect to development and research of biopharmaceutical products; information service relating to medicines; advisory services regarding the research and development of pharmaceutical products; information services concerning the research and development of pharmaceutical products; providing information relating to the preparation and dispensing of medicines; consultation with respect to pharmacy; pharmaceutical advice; advisory services with respect to nutrition; dietetic services; medical treatment of allergies
- D10000: "BIOSCIENCES"
- GS0421: Scientific and technological research services in the field of medicine; medical and pharmacological research services; laboratory analysis in the field of bacteriology; scientific research and analysis in the field of medicine; design and development of medical technologies; technical advice with respect to technical research in the field of food and beverages; technical advice with respect to research services concerning food and food supplements; development of new products; research laboratory services in the field of pharmaceuticals; providing scientific research services; providing information and results relating to scientific research from an online searchable database; preparation of reports concerning scientific research; preparation of scientific reports; research for new products for others; product research for others; chemical technology research; research and development in the field of biotechnology; research and development of new products; research and development of new products for third parties; scientific and industrial research in the field of medicine; product research for others in the field of food products; research for developing new products; industrial analysis and research services in the field of chemistry; assessment of the effectiveness of industrial chemical products; consultant services in the field of scientific research; providing advisory information services in the field of scientific instruments; advice relating to scientific research; providing advice in connection with medical science; professional advice relating to food technology; technical consultancy with respect to product development; development of medicines; development and testing of chemical production methods; scientific laboratory services
Case File Event Statements
-
9/25/2023 - a year ago
26 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
9/25/2023 - a year ago
25 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
9/20/2023 - a year ago
24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
6/20/2023 - a year ago
23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED
Type: NRCC
-
6/20/2023 - a year ago
22 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
4/4/2023 - a year ago
21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
4/4/2023 - a year ago
20 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
3/15/2023 - a year ago
19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
2/27/2023 - a year ago
18 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
2/27/2023 - a year ago
17 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
2/27/2023 - a year ago
16 - ASSIGNED TO LIE
Type: ALIE
-
2/27/2023 - a year ago
15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
2/27/2023 - a year ago
14 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
2/27/2023 - a year ago
13 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
2/17/2023 - a year ago
12 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
2/16/2023 - a year ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/16/2023 - a year ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/12/2022 - 2 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
8/22/2022 - 2 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
8/22/2022 - 2 years ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
7/28/2022 - 2 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
7/27/2022 - 2 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
7/25/2022 - 2 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/3/2022 - 2 years ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
4/29/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
4/28/2022 - 2 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR